Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...

This discovery is significant because there are currently no effective treatments for any type of dementia, including FTD.

In a report released yesterday, Evan Seigerman from BMO Capital maintained a Hold rating on Biogen (BIIB – Research Report), with a price ...

Researchers have discovered that suppressing a nucleolar complex can reduce Alzheimer’s-related protein toxicity. Scientists ...

INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

This step is important to make sure that only the best and safest treatments are tested on humans in clinical trials. The team examined postmortem brain tissues from Alzheimer's patients using ...

New expensive but disease-modifying treatments are expected to foster Alzheimer’s disease market growth globally, according ...

characterised by cognitive impairment and memory loss. Professor Götz said current medications target disease progression and symptoms but don't offer patients a cure. "Therapeutic ultrasound ...

Former study was recently accepted in a peer-reviewed medical journal with focus on Alzheimer’s disease titled, “Blarcamesine for the treatment ... based on current information and ...

There is a potential link between Alzheimer's disease and the herpes simplex virus-1 (HSV-1), which is a common cause for ...

In July 2024, people living with early Alzheimer’s and organizations such as the Alzheimer’s Association celebrated FDA ...

Open to all Mississippi residents, the conference will feature expert-led sessions on Alzheimer’s disease, caregiving ...